Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Invasive Cancer”

2,313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,313 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Not applicableActive Not RecruitingNCT07465822
What this trial is testing

The Learning Curve of a Gynecology and Obstetrics Resident Performing Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) Hysterectomy in a University Hospital

Who this might be right for
Abnormal Uterine Bleeding, UnspecifiedBenign Gynecological DiseaseAdenomyosis of Uterus+1 more
Cukurova University 19
Very early researchStudy completedNCT03387553
What this trial is testing

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Cancer, Male+5 more
H. Lee Moffitt Cancer Center and Research Institute 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Not applicableLooking for participantsNCT06867445
What this trial is testing

Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Who this might be right for
Cervical CancersVaginal Cancers
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 64
Not applicableStudy completedNCT03172572
What this trial is testing

A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers

Who this might be right for
Pancreatic NeoplasmsPancreas CystPancreas Cancer
S (Sjors) Klompmaker, MD 4,220
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableNot Yet RecruitingNCT07781956
What this trial is testing

Home-Based Supportive Care Program for NMIBC Patients Receiving Intravesical Perfusion: Construction and Preliminary Application

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Nanjing First Hospital, Nanjing Medical University 40
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Not applicableStudy completedNCT01508273
What this trial is testing

Lifestyle Intervention for High Risk Cancer Survivors

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1,150
Not applicableLooking for participantsNCT07120529
What this trial is testing

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Who this might be right for
Cervical CancerHysterectomy
Medical University of Silesia 300
Testing effectiveness (Phase 2)Study completedNCT00002873
What this trial is testing

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

Who this might be right for
Breast Cancer
Radiation Therapy Oncology Group
Not applicableLooking for participantsNCT06536439
What this trial is testing

Planning Operative Strategy Using a Digital Renal Artery Clamping Tool

Who this might be right for
Kidney CancerKidney NeoplasmsKidney Diseases+3 more
University Hospital, Ghent 235
Testing effectiveness (Phase 2)Study completedNCT02324595
What this trial is testing

Minimally Invasive Interval Debulking Surgery in Ovarian Neoplasm: a Feasibility Study

Who this might be right for
Stage IV Ovarian CarcinomaEffects of ChemotherapyPeritoneal Cavity Cancer
Catholic University of the Sacred Heart 30
Testing effectiveness (Phase 2)Study completedNCT00794950
What this trial is testing

Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Tract Urothelial Carcinoma
University of Michigan 43
Early research (Phase 1)UnknownNCT04134000
What this trial is testing

Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)

Who this might be right for
Invasive Bladder Cancer
Fundacion Oncosur 40
Testing effectiveness (Phase 2)Study completedNCT01687244
What this trial is testing

Intravesical Administration of rAd-IFN/Syn3 in Patients With BCG-Refractory or Relapsed Bladder Cancer

Who this might be right for
Superficial Bladder Cancer
FKD Therapies Oy 40
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Next Page